EP3639031A4 - IHC ANTIGEN IMAGING SCALE EXTRAPOLATION PROCESS - Google Patents

IHC ANTIGEN IMAGING SCALE EXTRAPOLATION PROCESS Download PDF

Info

Publication number: EP3639031A4
Authority: EP; European Patent Office
Prior art keywords: imaging scale; extrapolation process; ihc; antigen imaging; scale extrapolation
Prior art date: 2017-06-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP18816945.2A

Other languages

German (de)

French (fr)

Other versions

EP3639031A1 (en

Inventor

Frederick Knute Husher

Jee Jong Shum

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Shenzhen Prs Ltd

Original Assignee

Sunstone Scientific Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-06-15

Filing date

2018-06-15

Publication date

2021-05-05

2018-06-15 Application filed by Sunstone Scientific Ltd filed Critical Sunstone Scientific Ltd

2020-04-22 Publication of EP3639031A1 publication Critical patent/EP3639031A1/en

2021-05-05 Publication of EP3639031A4 publication Critical patent/EP3639031A4/en

Status Withdrawn legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/44—Sample treatment involving radiation, e.g. heat
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Pathology (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Rehabilitation Therapy (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Investigating Or Analysing Biological Materials (AREA)

EP18816945.2A 2017-06-15 2018-06-15 IHC ANTIGEN IMAGING SCALE EXTRAPOLATION PROCESS Withdrawn EP3639031A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201762520319P	2017-06-15	2017-06-15
US201762520187P	2017-06-15	2017-06-15
PCT/CN2018/091689 WO2018228577A1 (en)	2017-06-15	2018-06-15	Method for ihc antigen imaging scale extrapolation

Publications (2)

Publication Number	Publication Date
EP3639031A1 EP3639031A1 (en)	2020-04-22
EP3639031A4 true EP3639031A4 (en)	2021-05-05

Family

ID=64660854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP18816945.2A Withdrawn EP3639031A4 (en)	2017-06-15	2018-06-15	IHC ANTIGEN IMAGING SCALE EXTRAPOLATION PROCESS

Country Status (5)

Country	Link
EP (1)	EP3639031A4 (en)
JP (1)	JP7440411B2 (en)
KR (1)	KR102342988B1 (en)
CN (1)	CN110753846B (en)
WO (1)	WO2018228577A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006007726A1 (en) *	2004-07-20	2006-01-26	Umedik Inc.	Method to measure dynamic internal calibration true dose response curves
US20070141723A1 (en) *	2005-12-16	2007-06-21	Sompuram Seshi A	Immunohistochemistry staining controls
WO2009085576A2 (en) *	2007-12-28	2009-07-09	Spring Bioscience Corporation	Positive control cell pellets for immunohistochemistry and methods of use thereof
WO2014114009A1 (en) *	2013-01-25	2014-07-31	Wang Xiaoya	Immunohistochemical quality control reference object and quality control method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080070324A1 (en) *	2002-07-15	2008-03-20	Floyd Alton D	Quantity control device for microscope slide staining assays
WO2004046685A2 (en) *	2002-07-15	2004-06-03	Technical Instrument San Francisco	Quality control of assays
GB0725239D0 (en) *	2007-12-24	2008-02-06	Oncimmune Ltd	Calibrator for autoantibody assay
WO2012078138A1 (en) *	2010-12-07	2012-06-14	Wei-Sing Chu	Cell array quality control device for pathological analysis
GB2490652A (en) *	2011-04-18	2012-11-14	Microtest Matrices Ltd	Methods of quantifying antibodies, especially IgE antibodies in a sample
CN102435728B (en) *	2011-09-07	2014-06-25	福州大学	Preparation method for positive control substance for inspection and control of quality in immunohistochemical process
WO2013090567A2 (en)	2011-12-13	2013-06-20	Lab Vision Corporation	Immunohistochemical validation devices and methods
CN103116029B (en) *	2013-01-29	2015-01-21	福州迈新生物技术开发有限公司	Determining method for sensitivity and affinity of second antibody color appearance system for immunohistochemistry
SG11201508139UA (en) *	2013-03-30	2015-11-27	Clarient Diagnostic Services Inc	Microscope slides with quality controls thereon
WO2015187158A1 (en) *	2014-06-04	2015-12-10	Indevr, Inc.	Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins
US20160258848A1 (en) *	2015-03-04	2016-09-08	Agilent Technologies, Inc.	Methods and compositions for multiplex tissue section analyses using visible and non-visible labels
CA2979559A1 (en) *	2015-03-27	2016-10-06	Opko Diagnostics, Llc	Prostate antigen standards and uses thereof
WO2017087847A1 (en) *	2015-11-20	2017-05-26	Oregon Health & Science University	Multiplex immunohistochemistry image cytometry

2018
- 2018-06-15 WO PCT/CN2018/091689 patent/WO2018228577A1/en not_active Ceased
- 2018-06-15 KR KR1020207001301A patent/KR102342988B1/en active Active
- 2018-06-15 EP EP18816945.2A patent/EP3639031A4/en not_active Withdrawn
- 2018-06-15 CN CN201880038946.3A patent/CN110753846B/en active Active
- 2018-06-15 JP JP2020519175A patent/JP7440411B2/en active Active

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006007726A1 (en) *	2004-07-20	2006-01-26	Umedik Inc.	Method to measure dynamic internal calibration true dose response curves
US20070141723A1 (en) *	2005-12-16	2007-06-21	Sompuram Seshi A	Immunohistochemistry staining controls
WO2009085576A2 (en) *	2007-12-28	2009-07-09	Spring Bioscience Corporation	Positive control cell pellets for immunohistochemistry and methods of use thereof
WO2014114009A1 (en) *	2013-01-25	2014-07-31	Wang Xiaoya	Immunohistochemical quality control reference object and quality control method

Also Published As

Publication number	Publication date
KR20200041861A (en)	2020-04-22
CN110753846B (en)	2024-03-26
JP7440411B2 (en)	2024-02-28
JP2020523616A (en)	2020-08-06
EP3639031A1 (en)	2020-04-22
WO2018228577A1 (en)	2018-12-20
KR102342988B1 (en)	2021-12-27
CN110753846A (en)	2020-02-04

Publication	Publication Date	Title
IL272274A (en)	2020-03-31	Antibodies 4H-7B methods for their use
IL272349A (en)	2020-03-31	ANTI-CD137 antibodies
EP3417768C0 (en)	2024-01-17	IMAGING METHODS
MA51428A (en)	2020-11-04	MULTIVALENT CHEMERICAL ANTIGEN RECEIVER
EP3351089A4 (en)	2019-05-01	IMAGE EVALUATION METHOD
MA50505A (en)	2020-09-09	2 + 1 BISPECIFIC ANTIBODIES (CONTORSBODIES)
EP3764766A4 (en)	2022-02-23	SEED IMAGING
HUE053239T2 (en)	2021-06-28	Humanized tau antibodies for the treatment of Alzheimer's disease
EP3508814A4 (en)	2020-03-11	IMAGING DEVICE
EP3852631A4 (en)	2022-04-13	IMAGING PROCESS
PL3283110T3 (en)	2022-06-27	ANTIBODIES TARGETED AGAINST INTERLEUKIN-36 RECEPTOR (IL-36R)
EP3399903A4 (en)	2019-08-21	DEVICE FOR INTRODUCING ENDOTRACEAL TUBE
EP3308209A4 (en)	2019-02-27	MULTISPECTRAL IMAGING APPARATUS
EP3379317A4 (en)	2019-03-20	IMAGING LENS
EP3422410A4 (en)	2019-09-11	IMAGING DEVICE AND METHOD FOR MANUFACTURING IMAGING DEVICE
EP3396937A4 (en)	2019-05-15	IMAGING DEVICE
EP3264969A4 (en)	2019-02-13	DEVICE FOR INTRODUCING ENDOTRACEAL TUBE
EP3413015A4 (en)	2019-09-04	IMAGING DEVICE
EP3343912A4 (en)	2019-04-10	IMAGING DEVICE
EP3424404A4 (en)	2019-11-27	OPHTHALMOLOGICAL IMAGING APPARATUS
EP3398957A4 (en)	2019-08-14	PROCESS FOR SYNTHESIZING ETTEAL ALLOYDE
DK3443401T3 (en)	2022-10-24	SUPER RESOLUTION IMAGING
EP3490460A4 (en)	2020-03-11	URINE SAMPLING PROCESS
EP3399303A4 (en)	2019-01-23	PORTABLE BACKCAST IMAGER AND ITS IMAGING METHOD
EP3479142C0 (en)	2023-11-15	RADIATION IMAGING APPARATUS

Legal Events

Date	Code	Title	Description
2018-12-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2020-03-20	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2020-03-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2020-04-22	17P	Request for examination filed	Effective date: 20200113
2020-04-22	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2020-04-22	AX	Request for extension of the european patent	Extension state: BA ME
2020-09-23	DAV	Request for validation of the european patent (deleted)
2020-09-23	DAX	Request for extension of the european patent (deleted)
2021-05-05	A4	Supplementary search report drawn up and despatched	Effective date: 20210401
2021-05-05	RIC1	Information provided on ipc code assigned before grant	Ipc: G01N 33/564 20060101AFI20210326BHEP Ipc: G01N 33/574 20060101ALI20210326BHEP Ipc: G01N 33/543 20060101ALI20210326BHEP
2021-06-09	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SHENZHEN PRS LIMITED
2023-09-28	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2023-11-01	17Q	First examination report despatched	Effective date: 20230927
2025-10-31	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2025-12-03	18D	Application deemed to be withdrawn	Effective date: 20250722